Trials / Completed
CompletedNCT00046137
Combined Use of Teriparatide and Raloxifene in Postmenopausal Women With Osteoporosis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Eli Lilly and Company · Industry
- Sex
- Female
- Age
- 45 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare treatment with both teriparatide and raloxifene with teriparatide alone. The study will evaluate any side effects that may be associated with the two drugs and may help to determine whether teriparatide and raloxifene together can help patients with osteoporosis more than teriparatide alone.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | teriparatide | |
| DRUG | raloxifene | |
| DRUG | placebo |
Timeline
- First posted
- 2002-09-23
- Last updated
- 2006-07-20
Locations
13 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00046137. Inclusion in this directory is not an endorsement.